The CD23 Count test measures CD23-positive B lymphocytes in EDTA blood, helping evaluate B-cell activation and identify certain lymphoid disorders. It is particularly useful in diagnosing chronic lymphocytic leukemia and other B-cell malignancies. Metropolis Healthcare uses advanced flow cytometry to ensure precise and reliable CD23 count results. These results support clinicians in accurate diagnosis and ongoing hematological evaluation.
Price:
Rs. 2,390.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: C0066
Frequently Asked Questions (FAQ's):
What does this test include?
This test measures CD23-positive B-cell counts in EDTA blood, performed with accuracy by Metropolis Healthcare.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses flow cytometry to detect and quantify CD23 expression on lymphocytes.
Who should take this test?
Patients with suspected lymphoid malignancies or abnormal immune screening can benefit at Metropolis Healthcare.
Why is CD23 testing important?
Metropolis Healthcare uses this test to help identify specific B-cell disorders and activation patterns.
Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs an EDTA blood sample.
What do high CD23 counts indicate?
High counts at Metropolis Healthcare may suggest chronic lymphocytic leukemia or B-cell activation.
What do low CD23 counts mean?
Low levels at Metropolis Healthcare can reflect reduced B-cell activity or immune suppression.
How long does it take to get results?
Metropolis Healthcare provides timely and reliable results to support clinical decision-making.